Results for tag: "Wilms Tumor Drug"

The Wilms Tumor Drug market is a subset of the larger Liver and Kidney Disorders Drugs market. Wilms Tumor is a rare type of kidney cancer that primarily affects children. Treatment for Wilms Tumor typically involves a combination of surgery, chemotherapy, and radiation therapy. Drugs used to treat Wilms Tumor are typically targeted therapies, which are designed to specifically target the cancer cells while leaving healthy cells unharmed. The Wilms Tumor Drug market is highly competitive, with a number of companies offering treatments for the disease. Companies in the market include Novartis, Pfizer, Merck, and Bristol-Myers Squibb. These companies offer a variety of treatments, including targeted therapies, chemotherapy, and radiation therapy. Additionally, some companies are developing new treatments for Wilms Tumor, such as immunotherapies and gene therapies. Show Less Read more